|
SU1552595A1
|
|
Ominooxypropoxyindole derivatives possessing prolonged beta-adrenoblocking action
|
|
SU1556079A1
|
|
Method of obtaining 3-amino-4-arylppyridosin [4,3- ] indole derivatives
|
|
SU1557964A1
|
|
Method of 2-diethylamine-2ъ,6ъ-acetylidide synthesis
|
|
SU1490115A1
|
|
Method of producing n-acetyl-2-chloro-3-iminoindoline hydrochloride
|
|
SU1416489A1
|
|
Method of producing derivatives of 5-oxybenzofurane
|
|
SU1334651A1
|
|
Method of separating chlorine hydrate d, l-treo-1-p-nitrophenyl-2-aminopropandiol-1,3
|
|
RU1258046C
|
|
Composition possessing antiviral action
|
|
RU1327491C
|
|
Composition rossessing antiviral action
|
|
SU1251678A1
|
|
Method of determining inhibitors of bacterial dihydrophalatreductase from derivatives of quinoxaline
|
|
SU1227998A1
|
|
Method of fubromegan quantitative determination
|
|
SU1414845A1
|
|
1-thiokarbamylmethylpyrrolidine-2-tion- possessing nootrofic activity and method of production thereof
|
|
SU1109638A1
|
|
Method of determination of sodium methylsulphonate@-amynobensenethyosemicarbason monohydrate
|
|
SU1133515A1
|
|
Method of quantitative determination of iodinated aromatic carbonic acid salts
|
|
SU1443235A1
|
|
Local radio-protection agent
|
|
SU1092411A1
|
|
Method of determination of tartaric acid in urodanum preparation
|
|
SU1085204A1
|
|
Preparation having cytostatic antitumoral and antireductase effect
|
|
SU1072447A1
|
|
A-nor-3-aza-chloroacetyl-5b-cholestane displaying antitumor activity
|
|
SU1098228A1
|
|
Hydrosulfite derivative of (1-phenyl-2-methylindeno /1,2-b/ pyrrol-4-onyl-3)glyoxal possessing antiviral activity
|
|
SU1045573A1
|
|
2-alpha-mercaptoethylimino-pyrrolidines,-hexahydroazepines or -piperidines possessing antihypertensive activity
|
|
SU1068417A1
|
|
Process for preparing derivatives of 1,2-dioxo-3-chloronaphthalene or 4,5-dioxoindole
|
